Market Overview

Speakers Highlight Quality Improvement and Patient-Centered Care Using ivWatch Technology


Fall speaking schedule delivers opportunities to hear from ivWatch
experts and end-users

Representatives and customers of ivWatch,
the only provider of continuous monitoring devices for the early
detection of intravenous (IV) infiltrations and extravasations, will
share their experience and discuss current projects at several upcoming
association events in multiple health care segments including vascular
access, pediatrics and person-centered care.

  • On September 14, panelists from Cincinnati Children's Hospital and
    Medical Center will participate in a pre-conference symposium at the
    Association for Vascular Access (AVA) 2018 Annual Scientific Meeting.
    Sylvia Rineair MSHA, BSN, RN, VA-BC, clinical director of the Vascular
    Access Team will be joined by Lindsay Cipriani MSN, RN, M. Ed., an
    education specialist in the Pediatric Intensive Care Unit (PICU), to
    discuss a quality improvement project using the ivWatch Model 400 for
    early detection of peripheral IV complications.
  • On September 18, ivWatch Chief Nursing Officer, Susan Brown MSN, MSED,
    VA-BC, will facilitate a session at AVA's 2018 Annual Scientific
    Meeting titled, "Improve Early Detection of Infiltration and
    Extravasation Events: Training Non-Vascular Access Team Members on
    Proven Methods, Protocols, and Technology."
  • On September 26, all interested parties can register
    to hear from leaders at Cincinnati Children's Hospital Medical Center
    during the webinar, "Paving the Way: Early Detection Technology -
    PIVIE Harm Reduction" hosted by the Children's Hospital Association
  • On September 28-29, Brown will present at the Emergency Nurses
    Association (ENA) Annual Conference on "IV Infiltration and
    Extravasation Risks and Early Detection" covering required skills and
    tools in the emergency setting for IV therapy care from intake to
  • On October 9, Brown will present at the Planetree International
    Conference on Person-Centered Care. She will discuss improving patient
    experiences during the session "New Standard of Care for PIVs,
    Improving Patient Outcomes by Early Detection of Infiltrations for
    High-Risk Patients."

"I am thrilled to have been accepted to speak at some of the medical
industry's best trade shows to share what I've learned throughout my
career, educate future leaders on the new advancements in vascular
access, as well as promote the successes of our customers and the
quality improvements offered to their patients," said Brown, whose
clinical background is in pediatrics. "Every opportunity we have to
speak to hospital leadership and the nurses on the frontlines, the
closer we are to keeping more people safe from preventable IV harm."

Infiltration studies are available, and the awareness of the issue is
growing, yet, it remains an underreported occurrence. ivWatch is
committed to education on the prevalence of IV complications,
identifying the risks of infiltration, assessment methods and how
ivWatch technology fits into clinical workflows to improve patient
safety and outcomes. The company also sponsors a website that focuses on
simplified IV information,,
which provides resources to medical staff for their patients.

To learn more about ivWatch and upcoming event participation, visit

About ivWatch:

 is the leading medical device manufacturer and biosensor
technology company focused on improving patient safety and the
effectiveness of intravenous therapy. Our dedicated and passionate team
is focused on our company vision of eliminating patient harm caused by
infiltrations and extravasations. Through our innovative monitored IV
solutions, we help minimize the risks associated with adverse IV events.
Follow us on Twitter @ivWatch or
Facebook @ivWatchLLC

View Comments and Join the Discussion!